Portfolio Update

RNS Number : 6960H
Intl. Biotechnology Trust PLC
19 August 2016
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

 

Portfolio Update as at 31 July 2016

 

 

Net Assets

£223m

Net Assets per share

591p

Share price

530p

Total value of unquoted investments

£25m

Total number of portfolio companies

84

 

Top Ten Holdings

 

Company Name

% NAV

Celgene

7.1

Regeneron

6.5

Actelion

4.7

Alexion

4.7

Incyte

4.0

Amgen

3.7

Medivation

3.7

Vertex

3.6

Novo

3.4

Biogen

3.4


-----------

Total

44.8

 

Geographical Allocation

% NAV

US & Canada

75

Europe & UK

25


-----------

Total

100

 

 

Quoted/Unquoted Allocation

% NAV

Quoted

89

Unquoted

11


-----------

Total

100

 

 

NAV % Market Cap

% NAV

Large Cap >USD10BN

68

Small Cap <USD1BN

26

Mid Cap =USD1-10BN

6


-----------

Total

100

 

 

NAV % by Therapeutic Areas

% NAV

Oncology

37

Orphan

22

CNS

11

Ophthalmology

8

Inflammation

5

Medtech

2

Other

15


-----------

Total

100

 

 

BNP Paribas Secretarial Services Limited

Company Secretary

 

19 AUGUST 2016


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBDGDIIBBBGLC
Investor Meets Company
UK 100

Latest directors dealings